NTRK Webinar Seires

The Development of TRK Inhibitors in Cancer is part of a webinar series designed to help oncologists and pathologists learn best practices in testing for TRK.

 

Select a topic below to watch webinars, access scientific papers, and view whole slide pathology

This platform is supported by an educational grant from Bayer

Tumors with NTRK Fusions in Head and Neck Pathology

Presented By Alena Skalova

Provided by Celerity Education

Approaches to TRK, RET, MET and other Emerging Mutations in Lung Cancer Pathology

Presented By Patrick Pauwels

Provided by Celerity Education

Testing for TRK and other Targeted Mutations in Pediatric Cancers

Presented By Jessica Davis

This webinar is supported by an educational grant from Bayer

Testing for TRK and other emerging targeted therapy driven approaches in head and neck cancers

Presented By Justin Bishop

This webinar is supported by an educational grant from Bayer

Testing for Clinically Actionable Mutations Including TRK in Sarcomas

Presented By Alex Lazar

This webinar is supported by an educational grant from Bayer

Practical guidance from an oncologist in finding TRK and other rare mutations in gastrointestinal cancer patients

Presented By Michael Pishvaian

This webinar is supported by an educational grant from Bayer

NGS Techniques to Detect TRK Fusions

Presented By Long Le

This webinar is supported by an educational grant from Bayer

Gynecological Tumors with NTRK and other Kinase Fusions

Presented By Michael Michal

This webinar is supported by an educational grant from Bayer

The development of TRK inhibitors in cancer: How a single patient and serendipity led to a novel FDA approval

Presented By Robert Doebele

This webinar is supported by an educational grant from Bayer